Dr. Richard Alan Lerner, MD – Chairman

Dr. Richard Alan Lerner is the Lita Annenberg Hazen Professor of Immunochemistry in the Department of Molecular Biology of The Scripps Research Institute (TSRI). Dr. Lerner serves as a Scientific Advisor at 5AM Venture Management LLC. He is the Founder of CovX Research LLC and served as President of The Scripps Research Institute until January 1, 2011.

He began his career in research in the Department of Experimental Pathology at The Scripps Research Institute in La Jolla/California, which he led from 1986 to 2011. In that capacity he directed all scientific activities at the Institute. Previously Dr. Lerner has held staff appointments at Scripps and the Wistar Institute in Philadelphia. He serves as the Chairman of Scientific Advisory Board and Member at Sorrento Therapeutics, Inc., Dyadic International, Inc. and Bay City Capital LLC. He also sits on the Scientific Advisory Boards for Protalix BioTherapeutics, Inc., Intra-Cellular Therapies, Inc., Senomyx Inc., Optimer Pharmaceuticals, Inc., and Xencor, Inc.

Dr. Lerner has been an Independent Director of Opko Health, Inc. since March 27, 2007, Abbott Molecular Inc. since February 2001, and Vysis Inc. since February 2001. He has been a Director of Sequenom, Inc since July 9, 2007 and works as its Lead Independent Director. He is the Director of Alavita Pharmaceuticals Inc. He serves as Member of the Scientific Advisory Council at Cancer Research Institute, Inc. He has been a Director of Intra-Cellular Therapies, Inc. since August 2013. He serves as a Director and Member of Scientific Advisory Board of SurroMed, Inc. He has been a Director of EMD Biosciences, Inc. since February 1997. He is on the Editorial Boards for the Journal of Virology, Molecular Biology and Medicine, Vaccine, In Vivo, Peptide Research, Bioorganic and Medicinal Chemistry Letters, Drug Targeting and Delivery, and a Senior Contributing Editor to PNAS and Chemistry and Biology, Bioorganic and Medicinal Chemistry, Molecular Medicine, Catalysis Technology, and Angewandte Chemie. He served as a Member of the Board of Directors and Member of the Scientific Advisory at PPD Biomarker Discovery Sciences, LLC. Dr. Lerner served as Director of Mondelez International, Inc. from January 2005 to May 23, 2012. He served as a Director of Teva Pharmaceutical Industries Limited from February 2012 to September 19, 2015. He served as a Director of Materia, Inc., and Xencor, Inc. Dr. Lerner served as a Member of the Advisory Board of TransAtlantic Capital Inc. since June 5, 2006. He served as a Director of the Research Institute of Scripps Clinic from 1986 to 1991. From 1982 to 1986, he served as the Chairman of the Department of Molecular Biology at the firm.

Dr. Lerner is the author of more than 400 scientific papers and holds honorary degrees from seven universities in Europe and America. He has also received numerous prestigious awards, including the Wolf Prize in Chemistry (Israel, 1995), the William B. Coley Award from the Cancer Research Institute (USA, 1999) and the Paul Ehrlich and Ludwig Darmstaedter Prize (Germany, 2003), and the Prince of Asturias Award for Scientific and Technical Research (Spain, 2012).Dr. Lerner has been the recipient of over 29 honors and prizes, including the Parke Davis Award in 1978, the San Marino Prize in 1990, the California Scientist of the Year Award in 1996, the University of California Presidential Medal in 2002. He has received numerous honors including election to the National Academy of Sciences, the Royal Swedish Academy of Sciences, and the United States National Academy of Sciences.

He has had a 30 year career in biomedical research, with experience in several diverse areas. He is known for his innovative work of converting antibodies into enzymes, thus permitting the catalysis of chemical reactions considered impossible to achieve by classical chemical procedures. He has been a Scientific Advisory Board Member of Opko Health, Inc. He is an expert in the field of catalytic antibodies. Dr. Lerner oversaw the establishment of Scripps Florida. He received Post-Doctoral training at Scripps and Research Foundation in Experimental Pathology. He holds honorary doctorates from esteemed academic institutions including the Technion—Israel Institute of Technology and University of Oxford.Dr. Lerner did undergraduate work at Northwestern University and received B.M.S and M.D. from Stanford University Medical School in 1964, and interned at Palo Alto Stanford Hospital from 1964 to 1965.